24 November 2021
11am-12pm (AEDT)

Zoom Webinar
Register for Link

APR.Intern has partnered with MTPConnect‘s REDI program to offer medtech, biotech & pharma companies a $10,000 subsidy off the cost of engaging a PhD student intern over 3-6 months.

Join us to learn more about APR.Intern, the MTPConnect subsidy, and how your business can benefit from an industry-university collaboration.

This informative session will cover:

  • APR.Intern: An overview of the program; short-term PhD student placements that offer businesses cost-effective R&D support.
  • MTPConnect: APR.Intern’s partnership with MTPConnect and the subsidy available to businesses in the medtech, biotech & pharma sector.
  • Case Study: The Co-Founder and Chief Medical Officer of innovative medtech startup, Genepath will speak on his experience with APR.Intern.
  • Former PhD Intern: Sue Kweon will speak on her internship experience at Genepath and how she helped fast-track R&D.

Who should attend?

  • Medtech, biotech and pharma companies looking for a cost-effective solution to tackle R&D challenges.
  • PhD students and universities interested in supporting the development of crucial commercial research in the sector.


Director, MTPConnect REDI

Jarrod Belcher is the Director of MTPConnect’s REDI program, based in Melbourne. Previously, Jarrod was General Manager – Middle East North Africa for Site Group International, an ASX listed company providing Australian accredited and non-accredited training programs around the world. Throughout his career, he has been a passionate workforce development professional committed to assisting companies and industries achieve their potential through skilling workforces, across the Pacific, Asia and Middle East to government, NGO and corporate clients utilising innovative practices to embed and apply newly developed skills and behaviours.

He has led the delivery of the first vocational Bachelor of Biotechnology program delivered in TAFE and the delivery of biotechnology qualifications into China. Jarrod has a background in the biosciences with a BSc in Biochemistry and Molecular Biology from the University of Melbourne, and postgraduate qualifications in training and education and competitive manufacturing.

Co-Founder and Chief Medical Officer, Genepath

Glenn is a founder and the Chief Medical Officer for Genepath. He has cross-disciplinary expertise as a paediatric emergency specialist, a molecular geneticist, and an entrepreneur. With over 15 years experience in the public health sector, his strength is driving health system-wide uptake of innovative medical technology.

PhD Candidate, UNSW and Former PhD Intern, Genepath

Sue is currently a PhD scholar based at the School of Optometry & Vision Science (SOVS), UNSW. Her multidisciplinary research focuses on understanding how varying levels of hormones can have noticeable effect on the dry eye disease, involving meibomian gland dysfunction.

Earlier this year, Sue completed a three-month industry internship at medtech startup, Genepath, where she applied research expertise to commercial R&D.

Business Development Manager, APR.Intern

Michael has a 20 year professional career assisting innovative technology companies to access government funding, with experience in government, Big 4 management consulting and boutique advisory. He has wide industry exposure in technical areas including a broad spectrum of engineering disciplines, software development, construction, logistics, manufacturing, energy and national resources, agribusiness and the biotech sector.

Michael is passionate about working with scientists and engineers to access funds and resources to progress their R&D and thrives on the challenge of quickly coming to grips with unfamiliar concepts to solve challenging interdisciplinary problems.


Registrations have now closed for this event.

View the webinar recording here.

Info Session: MTPConnect Internship Subsidy (24 November)
Info Session: MTPConnect Internship Subsidy (24 November)
Info Session: MTPConnect Internship Subsidy (24 November)